Machine learning-based prediction of drug approvals using molecular, physicochemical, clinical trial, and patent-related features
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 14, 2022 Category: Drugs & Pharmacology Authors: Fulya Ciray Tunca Do ğan Source Type: research

The potential of natural sources for pancreatic lipase inhibitors: a solution of the obesity crisis?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 12, 2022 Category: Drugs & Pharmacology Authors: Xu-Dong Hou Xiao-Ya Qin Jie Hou Hui Tang Guang-Bo Ge Source Type: research

The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19)
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 12, 2022 Category: Drugs & Pharmacology Authors: Pasquale Pagliano Carmine Sellitto Tiziana Ascione Giuliana Scarpati Veronica Folliero Ornella Piazza Gianluigi Franci Amelia Filippelli Valeria Conti Source Type: research

Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 6, 2022 Category: Drugs & Pharmacology Authors: Israa A. Cheikh Chirine El-Baba Ali Youssef Najat A. Saliba Akram Ghantous Nadine Darwiche Source Type: research

The current progress in the use of boron as a platform for novel antiviral drug design
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 5, 2022 Category: Drugs & Pharmacology Authors: Shuo Wang Yujie Ren Zhao Wang Xiangyi Jiang Shujing Xu Xujie Zhang Shujie Zhao Waleed A Zalloum Xinyong Liu Peng Zhan Source Type: research

Virtual screening and zebrafish models in tandem, for drug discovery and development
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 30, 2022 Category: Drugs & Pharmacology Authors: David Hern ández-Silva Francisca Alcaraz-P érez Horacio P érez-Sánchez Maria Luisa Cayuela Source Type: research

Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 25, 2022 Category: Drugs & Pharmacology Authors: Barbara Miziak Stanis ław J Czuczwar Source Type: research

Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 25, 2022 Category: Drugs & Pharmacology Authors: Martin Perez-Santos Maricruz Anaya-Ruiz Luis Villafa ña-Diaz Gabriela S ánchez Esgua Source Type: research

Vaccines on demand, part II: future reality
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 24, 2022 Category: Drugs & Pharmacology Authors: Andrew J. Geall Zoltan Kis Jeffrey B. Ulmer Source Type: research

Insights into the operational model of agonism of receptor dimers
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 22, 2022 Category: Drugs & Pharmacology Authors: Jan Jakub ík Alena Rand áková Source Type: research

RNA-based drug discovery for spinal muscular atrophy: a story of small molecules and antisense oligonucleotides
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 22, 2022 Category: Drugs & Pharmacology Authors: Blanca Torroba Natsuko Macabuag Elisabeth M. Haisma Amy O ’Neill Maria E. Herva Roxana S. Redis Michael V. Templin Lauren E. Black David F. Fischer Source Type: research

Discovery of RNA-targeted small molecules through the merging of experimental and computational technologies
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 9, 2022 Category: Drugs & Pharmacology Authors: Ella Czarina Morishita Source Type: research

The state of the art of fetal hemoglobin-inducing agents
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 7, 2022 Category: Drugs & Pharmacology Authors: Aline Renata Pavan Juliana Romano Lopes Jean Leandro Dos Santos Source Type: research

Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 18, 2022 Category: Drugs & Pharmacology Authors: Sofia D ’Souza Prema Kv Seetharaman Balaji Source Type: research